CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Definitive Agreement for ‘Transformative’ Acquisition of Leading Manufacturer of Rare Cannabinoids

Sep 13, 2021

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has signed a definitive agreement to acquire BayMedica Inc., a private, U.S.-based company that specializes in the manufacturing and commercialization of rare cannabinoids. According to the announcement, the acquisition is expected to be final in the coming weeks, subject to standard closing conditions. The strategic move is designed to firmly establish INM as a leader in the manufacturing and commercialization of rare cannabinoids as well as strengthen the company’s position within growing consumer health and wellness cannabinoid markets. The acquisition includes BayMedica’s pipeline and several planned product launches, which will help InMed transition into a revenue-generating company. With the acquisition, InMed anticipates becoming a global leader in the manufacturing of rare cannabinoids, with expertise in three distinct and complementary cannabinoid manufacturing approaches. The company anticipates that its proprietary cannabinoid manufacturing process, IntegraSyn(TM), combined with BayMedica’s synthetic biology and chemical synthesis capabilities, will provide flexibility to choose the most appropriate, cost-effective manufacturing method based on the cannabinoid and appropriate quality specifications for the desired market segment. “This is a transformative transaction for InMed,” said InMed president and CEO Eric A. Adams in the press release. “This acquisition gives us a breadth of synthetic cannabinoid manufacturing capabilities to deliver high-quality, cost-effective rare cannabinoids for any segment of the market from consumer packaged goods (CPG) to prescription pharmaceuticals. . . . This transaction transforms InMed into a revenue-generating company, providing tangible value for our shareholders. BayMedica has demonstrated a rapid increase in sales since initiating commercialization, and we expect to grow these revenues considerably in the short-to-medium term. We believe this segment of the industry is reaching an inflection point as commercial viability is being achieved as well as increased awareness and appreciation for bio-identical, synthetically produced cannabinoids.”

To view the full press release, visit https://cnw.fm/fOqaY

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”); the company is developing IntegraSyn(TM) to produce pharmaceutical-grade cannabinoids. INM is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based medicines. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is part of the InvestorBrandNetwork.

More News

Union attacks NatWest plans to get workers back to the office
Oct 20, 2026
Union attacks NatWest plans to get workers back to the office

The bank says workers will be required to attend the office at least two days a week from February.

A ‘Doom Loop’ Threatens France as Populism Confronts Markets
Oct 20, 2026
A ‘Doom Loop’ Threatens France as Populism Confronts Markets

The turmoil shows the profound challenges facing governments stuck between unhappy citizens and wary bond investors.

Bereaved families could face 'unjust' tax bill after civil service pension delays
Oct 20, 2026
Bereaved families could face 'unjust' tax bill after civil service pension delays

The chairman of Parliament's Public Accounts Committee says families should not be taxed through no fault of their own.

Jobless rate falls but small firms cut back hiring
Oct 20, 2026
Jobless rate falls but small firms cut back hiring

Small firms cite labour costs as a key factor in scaling back hiring, the Office for National Statistics says.

£30 rise in payments for crisis-hit households
Oct 20, 2026
£30 rise in payments for crisis-hit households

More money is made available through a resilience fund for hard-pressed households in Sheffield.

'I'm fed up of swiping': The singles choosing dating events over apps
Oct 20, 2026
'I'm fed up of swiping': The singles choosing dating events over apps

The BBC hears from people who think dating events are better value for money than dating apps.

Chancellor rejects calls to raise Capital Gains Tax in Budget
Oct 20, 2026
Chancellor rejects calls to raise Capital Gains Tax in Budget

Influential Labour figures had been pushing for equalising CGT and income tax, but critics have said this could drive wealthy people out of Britain.

How Do Airports Prepare for a Plane Crash? Go Inside JFK’s Disaster Drill.
Oct 20, 2026
How Do Airports Prepare for a Plane Crash? Go Inside JFK’s Disaster Drill.

U.S. airports are required to hold a full-scale disaster drill every three years. Go inside a simulated plane crash at Kennedy Airport last weekend.

Burnham vows end to 'rip-off parking charges' under new rules
Oct 20, 2026
Burnham vows end to 'rip-off parking charges' under new rules

The changes come after concerns that penalties issued by private providers are too harsh and leave motorists unfairly punished.

What is the Budget and what could be in it?
Oct 20, 2026
What is the Budget and what could be in it?

Chancellor John Healey will set out his plans for UK taxes on 28 October.

Food aid charity under pressure from fuel costs
Oct 20, 2026
Food aid charity under pressure from fuel costs

FareShare South West says fuel costs are putting immense pressure on work helping thousands in need.

How is the US economy really doing under President Trump?
Oct 20, 2026
How is the US economy really doing under President Trump?

Ahead of the midterms Trump has boasted about the performance of the US economy. BBC Verify looks at inflation, jobs and economic growth in the country.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Marketers Log

Marketers Log is your personal Business & Finance news site to provide marketing or market-related news.

Newsletter